Back
NEUROSAFE
Lava
Non-Adhesive Embolizing Liquid for the embolization of lesions in the neurovasculature and peripheral vasculature, including arteriovenous malformations (AVM) and hypervascularized tumors.
Features
- Composed of a co-polymer (EVOH) + DMSO + Tantalum Powder to facilitate its visibility during the procedure.
- Kit components:
- One 1,5mL vial of LAVA
- One 1,5 mL vial of DMSO
- A 1mL syringe for DMSO (blue)
- Two 1 mL syringes for LAVA (white)
- Non-adhesive, latest EVOH co-polymer technology.
- Different degrees of viscosity (12cst, 18cst and 34cst), to adapt to different types of clinical treatment requirements.
- Improved fluidity, deeper penetration into the nidus and microvasculature.
- Release to achieve complete occlusion in a stable and controlled manner.
- Excellent visibility thanks to a greater micronization of the size of the tantalum powder.
Technical Specifications
| General characteristics | |
| Composition: | EVOH (Ethynyl-vinyl-Alcohol) + DMSO (solvent) + Tantalum |
| Available formats (According to EVOH Concentration) | 4% EVOH, 6% EVOH and 8% EVOH |
| Available Viscosity | 12cSt, 18cSt and 34cSt |
| Road volume | 1,5 ml |
| Recommended Microcatheter | DMSO Compatible |
| Visibility | Raised, micronized tantalum powder |
| Navigability | Depending on EVOH concentration |
| Quick release | Viscosity dependent depending on format |
Order information
| Order Information | |
| Highlighted | Description |
| LAVA-12 | Non-adhesive embolizing agent EVOH + DMSO + Tantalum Conc. 4% and 12cSt |
| LAVA-18 | Non-adhesive embolizing agent EVOH + DMSO + Tantalum Conc. 6% and 18cSt |
| LAVA-34 | Non-adhesive embolizing agent EVOH + DMSO + Tantalum Conc. 8% and 34cSt |